Kinnate Biopharma Inc.
(NASDAQ:KNTE)
$5.59
-0.17 (-2.95%)
At Close: 4:00 PM
KNTE Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
KNTE Stock Price Today
Kinnate Biopharma Inc. (KNTE) stock declined over -2.95% intraday to trade at $5.59 a share on NASDAQ. The stock opened with a loss of -0.35% at $5.74 and touched an intraday high of $5.99, falling -2.95% against the last close of $5.76. The Kinnate Biopharma Inc. in stock market went to a low of $5.58 during the session.
KNTE Stock Snapshot
$5.76
Prev. Close
248.64 Million
Market Cap
$5.58
Day Low
$5.74
Open
44.22 Million
Number of Shares
$5.99
Day High
-
P/E ratio
-2.52
EPS (TTM)
5.83
Cash Flow per Share
4.06
Free Float in %
7.81
Book Value
135,586
Volume
Contact Details
103 Montgomery Street
Suite 150 The Presidio of San Francisco
San Francisco, CA 94129
United States
Website:https://www.kinnate.com
Contact #:858 299 4699
Company Information
Employees84
Beta-
Sales or Revenue-
5Y Sales Change-
Fiscal Year EndsDec. 2021
SectorHealth Care
IndustryBiotechnology
About Company
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.
Frequently Asked Questions
What is the current Kinnate Biopharma Inc. (KNTE) stock price?
Kinnate Biopharma Inc. (NASDAQ: KNTE) stock price is $5.59 in the last trading session. During the trading session, KNTE stock reached the peak price of $5.99 while $5.58 was the lowest point it dropped to. The percentage change in KNTE stock occurred in the recent session was -2.95% while the dollar amount for the price change in KNTE stock was -$0.17.
KNTE's industry and sector of operation?
The NASDAQ listed KNTE is part of Biotechnology industry that operates in the broader Health Care sector. Kinnate Biopharma Inc. , a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States.
Who are the executives of KNTE?
Ms. Barbara Warren
Vice President of People & Culture
Dr. Robert Kania Ph.D.
Senior Vice President of Drug Discovery
Mr. Nima Farzan M.B.A.
Pres, Chief Executive Officer & Director
Mr. Mark A. Meltz
Chief Operating Officer, Gen. Counsel, Treasurer & Sec.
How KNTE did perform over past 52-week?
KNTE's closing price is 0.69% higher than its 52-week low of $3.3 where as its distance from 52-week high of $15.86 is -0.65%.
How many employees does KNTE have?
Number of KNTE employees currently stands at 84. KNTE operates from 103 Montgomery Street, Suite 150 The Presidio of San Francisco, San Francisco, CA 94129, United States.
Link for KNTE official website?
Official Website of KNTE is: https://www.kinnate.com
How do I contact KNTE?
KNTE could be contacted at phone #858 299 4699 and can also be accessed through its website. KNTE operates from 103 Montgomery Street, Suite 150 The Presidio of San Francisco, San Francisco, CA 94129, United States.
How many shares of KNTE are traded daily?
KNTE stock volume for the day was 135,586 shares. The average number of KNTE shares traded daily for last 3 months was 115.06 Thousands.
What is the market cap of KNTE currently?
The market value of KNTE currently stands at $248.64 Million with its latest stock price at $5.59 and 44.22 Million of its shares outstanding.